Which CLL patients would benefit from intensive therapy?
Updates to the iwCLL guidelines
Can chemoimmunotherapy in CLL treatment be replaced with novel agents?
From chemotherapy towards targeted therapies in CLL
Ibrutinib in combination with rituximab – the future of treating FL